Cancer Epidemiology, Biomarkers & Prevention, 2020
Inflammatory breast cancer (IBC) is an uncommon although highly lethal form of breast cancer. Exi... more Inflammatory breast cancer (IBC) is an uncommon although highly lethal form of breast cancer. Existing IBC research focuses mainly on United States or European populations, limiting current knowledge of patient profiles in Hispanic populations. Given the unique genetic admixture that exists in PR, we are interested in characterizing IBC within this population to broaden understanding of this disease. We designed a retrospective study which was deemed exempt by the UCC-IRB. A sample of breast cancer patient charts were reviewed at Manatí Medical Center and Pavia Hospital. Of these, 18 eligible subjects with a new primary diagnosis of IBC between 2012-2019 were identified and data was collected from oncologist and pathologist reports. On review, 78% of patients were negative for HER-2/neu receptor overexpression and there was a difference, although not statistically significant (p=0.09) compared to other receptor status. This result differs from other studied populations which place H...
Cancer Epidemiology, Biomarkers & Prevention, 2020
Inflammatory breast cancer (IBC) is an uncommon although highly lethal form of breast cancer. Exi... more Inflammatory breast cancer (IBC) is an uncommon although highly lethal form of breast cancer. Existing IBC research focuses mainly on United States or European populations, limiting current knowledge of patient profiles in Hispanic populations. Given the unique genetic admixture that exists in PR, we are interested in characterizing IBC within this population to broaden understanding of this disease. We designed a retrospective study which was deemed exempt by the UCC-IRB. A sample of breast cancer patient charts were reviewed at Manatí Medical Center and Pavia Hospital. Of these, 18 eligible subjects with a new primary diagnosis of IBC between 2012-2019 were identified and data was collected from oncologist and pathologist reports. On review, 78% of patients were negative for HER-2/neu receptor overexpression and there was a difference, although not statistically significant (p=0.09) compared to other receptor status. This result differs from other studied populations which place H...
Uploads
Papers by mayra Rivera